Literature DB >> 11747007

Magnetic resonance myocardial first-pass perfusion imaging: parameter optimization for signal response and cardiac coverage.

K M Bertschinger1, D Nanz, M Buechi, T F Luescher, B Marincek, G K von Schulthess, J Schwitter.   

Abstract

Fast imaging techniques allow monitoring of contrast medium (CM) first-pass kinetics in a multislice mode. Employing shorter recovery times improves cardiac coverage during first-pass conditions, but potentially flattens signal response in the myocardium. The aim of this study was therefore to compare in patients with suspected coronary artery disease (CAD) two echo-planar imaging strategies yielding either extended cardiac coverage or optimized myocardial signal response (protocol A/B, six/four slices; preparation pulse, 60 degrees /90 degrees; delay time, 10/120 msec; readout flip angle, 10 degrees /50 degrees; respectively). In phantoms and myocardium of normal volunteers (N= 10) the CM-induced signal increase was 2.5-3 times higher with protocol B (P < 0.005) than with protocol A. For the detection of individually diseased coronary arteries (> or =1 stenosis with > or =50% diameter reduction on quantitative coronary angiography (QCA)), receiver-operator characteristics of protocol B (signal upslope in 32 sectors/heart) yielded a sensitivity/specificity of 82%/73%, which was superior to protocol A (P < 0.05, N= 14). For the overall detection of CAD, the sensitivity/specificity of protocol B was 85%/81%. An adequate signal response in the myocardium is crucial for a reliable detection of perfusion deficits during first-pass conditions. The presented protocol B detects CAD with a sensitivity and specificity similar to scintigraphic techniques. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11747007     DOI: 10.1002/jmri.1219

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  13 in total

1.  Extended coverage first-pass perfusion imaging using slice-interleaved TSENSE.

Authors:  P Kellman; J A Derbyshire; K O Agyeman; E R McVeigh; A E Arai
Journal:  Magn Reson Med       Date:  2004-01       Impact factor: 4.668

Review 2.  Myocardial perfusion imaging by magnetic resonance imaging.

Authors:  Katherine C Wu
Journal:  Curr Cardiol Rep       Date:  2003-01       Impact factor: 2.931

Review 3.  MRI in coronary artery disease.

Authors:  Jörg Barkhausen; Peter Hunold; Kai-Uwe Waltering
Journal:  Eur Radiol       Date:  2004-09-04       Impact factor: 5.315

Review 4.  Cardiovascular magnetic resonance: structure, function, perfusion, and viability.

Authors:  David C Isbell; Christopher M Kramer
Journal:  J Nucl Cardiol       Date:  2005 May-Jun       Impact factor: 5.952

Review 5.  Magnetic resonance cardiac perfusion imaging-a clinical perspective.

Authors:  Peter Hunold; Thomas Schlosser; Jörg Barkhausen
Journal:  Eur Radiol       Date:  2006-05-03       Impact factor: 5.315

Review 6.  Myocardial perfusion imaging by cardiac magnetic resonance.

Authors:  Juerg Schwitter
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

Review 7.  Evaluation of ischemic heart disease.

Authors:  Dipan J Shah; Han W Kim; Raymond J Kim
Journal:  Heart Fail Clin       Date:  2009-07       Impact factor: 3.179

8.  Molecular imaging with endogenous substances.

Authors:  Klaes Golman; Jan H Ardenkjaer-Larsen; J Stefan Petersson; Sven Mansson; Ib Leunbach
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-20       Impact factor: 11.205

Review 9.  Evaluation of the microcirculation: advances in cardiac magnetic resonance perfusion imaging.

Authors:  Amit R Patel; Frederick H Epstein; Christopher M Kramer
Journal:  J Nucl Cardiol       Date:  2008 Sep-Oct       Impact factor: 5.952

10.  Superior diagnostic performance of perfusion-cardiovascular magnetic resonance versus SPECT to detect coronary artery disease: The secondary endpoints of the multicenter multivendor MR-IMPACT II (Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary Artery Disease Trial).

Authors:  Juerg Schwitter; Christian M Wacker; Norbert Wilke; Nidal Al-Saadi; Ekkehart Sauer; Kalman Huettle; Stefan O Schönberg; Kurt Debl; Oliver Strohm; Hakan Ahlstrom; Thorsten Dill; Nadja Hoebel; Tamas Simor
Journal:  J Cardiovasc Magn Reson       Date:  2012-09-02       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.